2
Most read
3
Most read
11
Most read
APPLICATION & SCOPE OF
BIOMATERIAL IN CONTROLLED
DRUG DELIVERY SYSTEM
PRESENTED BY:
STEFFI THOMAS
M.PHARM (PHARMACEUTICS),
1ST SEM
DEPARTMENT OF PHARMACY,
BARKATULLAH UNIVERSITY
CONTENTS
 WHAT ARE BIOMATERIALS
 APPLICATION IN PHARMACY
 SAFETY OF BIOMATERIALS
 BIOMATERIAL USED AS AN ADJUVANT IN
DRUG DELIVERY SYSTEM
 BIOMATERIAL AS ACTIVE PHARMACEUTICAL
AGENT
 SOURCES OF BIOMATERIALS
 REGULATORY GUIDELINES FOR
BIOMATERIALS
 FUTURE PROSPECTS OF BIOMATERIALS
 APPLICATIONS IN DISEASES
 APPLICATIONS AS DRUG DELIVERY SYSTEM
WHAT ARE BIOMATERIALS?
 Biomaterial is essentially a material that is
used and adopted for a medical application.
Biomaterials can have a benign function such
as being used for a heart valve, or may be
bioactive; used for more interactive purpose
such as hydroxy-apatite coated hip implants.
Biomaterials are also used everyday in dental
application, surgery and drug delivery.
 Eg. Intra ocular lens, substitute heart valves,
artificial hip joints
APPLICATION IN PHARMACY
 Cardiovascular medical devices(stents, grafts
and etc.)
 Orthopaedic and Dental applications(implant,
tissue engineered scaffolds and etc.)
 Ophthalmology applications(contact lens,
retinal prosthesis and etc.)
 Bioelectrodes and Biosensors
 Burns Dressings and Skin substitutes
 Sutures
 Drug Delivery Systems
SAFETY OF BIOMATERIALS
 Biomaterials are non-viable materials that can
be implanted to replace or repair missing
tissue. They may be of natural origin or
synthesized in a lab.
 When used in a medical application,
biomaterials can be implanted to replace or
repair missing tissue.
 Biomaterials, such as bone substitutes and
collagen membranes, are used regularly in
regenerative dentistry as well as for bone and
cartilage regeneration in Orthopedics
All Geistlich Biomaterials are derived from
natural bovine or porcine material and have
been developed to promote new bone or soft
tissue formation. Due to their similarity to
human tissue these material are optimally
suited to promote new bone formation and soft
tissue healing in the human body. They are
integrated into the tissue in the course of
healing process,or are broken down gradually
by the body’s metabolic process.
BIOMATERIALS USED AS AN
ADJUVANT IN DRUG DELIVERY
SYSTEMS
 ‘Drug delivery’ involves the design and
development of intelligent cargo carrier systems
that can deliver their cargo (pharmaceutical/
biological agent) to specific parts
(organs/tissues/cells) in the human body on
demand with control on the rate of delivery.
 Cargo-small molecules,DNA,RNA,Protein/peptide
 Vehicle/Carrier-Polymeric,Lipid,Inorganic
Present and future applications of biomaterials in controlled drug delivery system
 Controlled Drug Release in Colon
-For treatment of colon diseases such as
inflammatory bowel disease, amoebic dysentery,
Crohn’s disease and ulcerative colitis.
-To delay drug absorption after oral intake of the
drug.
-Protect drugs from harsh acidic environment
 Targeted Drug delivery
-In Cancer a need for drug targeting is done so
as to reduce side effects when drugs are
selectively targeted to tumor tissue rather than
administered systemically.
-Targeting Drugs to Endothelial Cells as these
cells play a crucial role in tumor development.
Tumor survival is highly dependent on blood
vessels which are comprised of endothelial
cells.
ACTIVE
PHARMACEUTICAL
AGENT Biomaterials also refer to biologically-derived
materials used for their structural rather than
biological properties, for example, collagen (a
protein found in the skin, connective tissues
and bone) as a cosmetic ingredient.
 Also carbohydrates(biotechnologically
modified) are being used as lubricants for
biomedical applications and as bulking agents
in pharmaceutical dosage form.
 Micro-organisms have proven to be an
excellent source of natural products including
polyketides and peptide antibiotics as well as
classes of other biological active compounds.
 Plants produce a variety of different types of
compounds including biologically active
proteins. Some of these types of compounds
are even shared with other organisms, and
they include such chemical families as lactines,
defensins, cyclotides and ribosome inactive
proteins. Ribosome inactive proteins are a
group of proteins exhibiting a wide spectrum of
biological activities, including a ribonucleolytic
activity for which the group is named. Thionins
are small proteins that selectively form disulfide
bridges with other proteins or form ion
channels in membrane. This ability to make
membrane more permeable suggests the
SOURCES OF BIOMATERIALS
 Biomaterials can be divided into 4 major
classes of materials, namely:
1. Polymers
2. Metals
3. Ceramics(including carbon, glass-ceramics,
and glasses)
4. Natural materials( those from both plants and
animals, algae, microorganisms)
REGULATORY GUIDELINES FOR
BIOMATERIALS
 Regulatory experts should be involved in basic
research activities undertaken by consortia so as
to raise awareness of the research decision
implications in terms of regulatory path.
 Regulation should not be looked in isolation but as
a factor contributing to the acceptability of the
products containing smart biomaterials by the
health care system.
 The requirements for evidence of safety and
efficacy don’t only come from regulators but also
from the end users and payers.
 CENTER FOR DEVICES AND
RADIOLOGICAL HEALTH(CDRH) ‘promotes’
and ‘protects’ the health of the public by
ensuring the safety and effectiveness of
medical devices and the safety of radiological
products.
 CDRH regulate devices, not materials and
medical procedures
FUTURE PROSPECTS OF
BIOMATERIALS
 SKIN TISSUE REGENERATION:In the field of
regenerative skin tissue engineering has had
several advancements to facilitate faster
wound healing and thereby restoration of skin.
Skin tissue regeneration is mainly based on the
use of suitable scaffold matrices. There are
several scaffold types, such as porous, fibrous,
microsphere, hydrogel, composite and acellular
etc.
 GOLD NANOPARTICLES: These are
spherical particles,nanorods,nanoshells and
nanocages. Gold nanoparticles due to their
enhanced and tunable optical properties have
been used for drug delivery, photothermal
therapy, cell tracking and sensing applications.
This can be thus used for tumor diagnostic
and treatment applications.
 CERAMIC NANOPARTICLES: Ceramic
nanoparticles which include alumina, zirconia,
hydroxyapatite tricalcium phosphate and silicon
nitride can be used for dental implants, hip
replacements and tissue engineering scaffolds.
APPLICATIONS IN DISEASES
 EYE DISEASES: for the treatment of scleratis
(sclera), glaucoma (retina), choroidal
melanoma (choroid), diabetic retinopathy
(retina), blindness, low vision by crossing
tissue barriers.
eg.contact lenses(poly(methyl methacrylate),
silicone hydrogels) ,glaucoma(silicone
impregnated with barium), vitreous
replacements(silicone oil)
 CARDIOVASCULAR DISEASES: Heart
valves, endovascular stents, vascular grafts,
stent grafts are common medical devices.
Different polymers and metals with or without
coating can be applied such as titanium,
polytetrafluoroethylene etc.
 BIOSENSORS AND BIOELECTRODES:
Bioelectrodes are sensors used to transmit
information into or out of the body. Surface or
transcutaneous electrodes used to monitor or
measure electrical events that occur in the
body are considered monitoring or recording
electrodes. Applications for recording
electrodes include electrocardiography,
Biosensor is a sensor that uses biological
molecules, tissues, organisms or principles to
measure chemical or biochemical
concentrations. Biomedical sensors can be
used to detect parameters: blood pressure or
temperature(physical parameters), blood
glucose.
 DENTAL MATERIALS: Restorative materials
have been used as tooth crowns and root
replacements. Four group of materials used in
dentistry are metals, ceramics, polymers and
composites. Dental materials are classified into
two categories:-preventive materials,
restoration materials.
APPLICATIONS AS DRUG
DELIVERY SYSTEMS
 Drug delivery systems introduced as
formulations or instruments which enable to
control he release rate of a biological agent(a
drug) in the target site. By increasing the size
the dosage in single dose administration, side
effects would appear so in order to reduce
them coatings with varying thickness, are
applied. Such formulations are termed as
“sustained release” or “prolonged release”
products.
 Macroscale DDS(“zero order” constant
delivery rate DDS).
-implants(e.g. Subcutaneous or intramuscular)
-inserts(e.g. vaginal,ophthalmic)
-topical DDS(e.g. skin patches)
 Nanoscale DDS(targeted DDS)
-injected nanocarrier DDS(e.g. PEGylated drugs,
polymer-drug conjugates, PEGylated
liposomes, PEGylated polymeric micelles)
 Macroscale and microscale DDS(site-specific,
sustained delivery rate DDS)
-Surface-coated DDS(e.g. oral tablets, catheters,
drug- eluting stents)
REFERENCES
 Lemons JE, Ratner BD, Hoffman AS, Schoen
FJ (2013) Biomaterials science an introduction
to materials in medicine, 3rd edn. Elsevier Ltd,
Amsterdam.
 Anusavice KJ(2003) Phillips’ science of dental
materials. Elsevier health sciences.
 www.cse.iitk.ac.in /-manindra / Website /...
/MFT-08-Dhirendra Katti.ppt.pdf
 Stikeman A.;Nano Biomaterials. Technology
Review November 2002
THANKS

More Related Content

PPT
Biomaterials – an overview
DOCX
High frequency trading
PPT
Drug delivery systems
PPTX
Stability Testing Of Pharmaceutical Dosage Form
PPT
Biomaterials in implants
PPTX
Conventional and novel drug delivery system.
PPT
Carbohydrate metabolism
PPT
Newer drug delivery systems
Biomaterials – an overview
High frequency trading
Drug delivery systems
Stability Testing Of Pharmaceutical Dosage Form
Biomaterials in implants
Conventional and novel drug delivery system.
Carbohydrate metabolism
Newer drug delivery systems

What's hot (20)

PPTX
Evolution of Bio-materials and applications
PPTX
Biomedical polymers
PPT
Polymers and Biomedical Applications.ppt
PPTX
Nanomaterials in biomedical application
PPTX
Characteristics of the biomaterials for tissue engineering application
PPTX
NANOPARTICULATE DRUG DELIVERY SYSTEM
PPTX
Biomaterials
PPTX
Biomedical applications of nanoparticles
PPT
Bio Nanocomposite Material Presentation
PPT
Nanotechnology Based Drug Delivery
PPTX
Solid lipid nanoparticles
PDF
Bit311 biomaterials unit 01-new
PPT
Nanopolymer
PPTX
Characterization of nanopartical
PPTX
Biomaterials
PPT
G:\Biomaterial Fabrication
PPT
Biomedical applications of quantum dots
PPTX
Biosensors
PPTX
Application of nanoparticals in drug delivery system
PPT
Smart polymers
Evolution of Bio-materials and applications
Biomedical polymers
Polymers and Biomedical Applications.ppt
Nanomaterials in biomedical application
Characteristics of the biomaterials for tissue engineering application
NANOPARTICULATE DRUG DELIVERY SYSTEM
Biomaterials
Biomedical applications of nanoparticles
Bio Nanocomposite Material Presentation
Nanotechnology Based Drug Delivery
Solid lipid nanoparticles
Bit311 biomaterials unit 01-new
Nanopolymer
Characterization of nanopartical
Biomaterials
G:\Biomaterial Fabrication
Biomedical applications of quantum dots
Biosensors
Application of nanoparticals in drug delivery system
Smart polymers
Ad

Similar to Present and future applications of biomaterials in controlled drug delivery system (20)

PDF
Targteted Drug Delivery - Technologies and Applications
DOCX
Designing of drug delivery system for biotechnology products considering stab...
PPTX
BIOTECHNOLOGY-foysalLast
PPTX
Nanotech Drug Delivery System: The Perfect Physio-Chemical deal for Biologica...
PPTX
local drug delivery in periodontics
DOC
biotechnology products.
PDF
Nano biotechnology, often referred to as nanobiotechnology, is a multidiscipl...
PDF
Hndds (cognosy)
PPTX
BiopolymersLecture3-2sdsdsddsdds015.pptx
PPTX
Implant medical devices.pptx
PDF
Biosimilar an overview
PPTX
Introduction to Pharmacology.pptx
PPTX
Applications of Environmental biotechnology.pptx
PPT
Pegylation & biosimilars global scenario
PPTX
nanoscience ppt.ppt of biophysics and nanotechnology
PPTX
Pharmaceutical Biotechnology
PPTX
Implant medical devices for pharmaceuticals
PDF
Nanotechnology in Medicine: Targeted Drug Delivery Systems (www.kiu.ac.ug)
PDF
Nanomedicine
PPTX
concept of biosimilars
Targteted Drug Delivery - Technologies and Applications
Designing of drug delivery system for biotechnology products considering stab...
BIOTECHNOLOGY-foysalLast
Nanotech Drug Delivery System: The Perfect Physio-Chemical deal for Biologica...
local drug delivery in periodontics
biotechnology products.
Nano biotechnology, often referred to as nanobiotechnology, is a multidiscipl...
Hndds (cognosy)
BiopolymersLecture3-2sdsdsddsdds015.pptx
Implant medical devices.pptx
Biosimilar an overview
Introduction to Pharmacology.pptx
Applications of Environmental biotechnology.pptx
Pegylation & biosimilars global scenario
nanoscience ppt.ppt of biophysics and nanotechnology
Pharmaceutical Biotechnology
Implant medical devices for pharmaceuticals
Nanotechnology in Medicine: Targeted Drug Delivery Systems (www.kiu.ac.ug)
Nanomedicine
concept of biosimilars
Ad

More from Steffi Thomas (13)

PPTX
Immunoblotting techniques-ELISA, Western blotting, Southern blotting
PPTX
Structure of immunoglobulins
PPTX
Analytical cosmetics:BIS specification and analytical methods for shampoo, sk...
PPTX
Basic principles of genetic engineering
PPTX
Study of cloning vectors and recombinant dna technology
PPTX
Use of microbes in industry. Production of enzymes-General consideration-Amyl...
PPTX
Chemistry and formulation of para phenylene diamine based hair dye
PPTX
Blood products:Collection, Processing and Storage of whole human blood, dried...
PPTX
Soap and syndet bars evolution and skin benefits
PPTX
An overview on coronavirus (COVID-19)
PPTX
Compositon and Formulation of Transdermal drug delivery system
PPTX
Excretion of drugs
PPTX
Quality-by-design(QbD) in pharmaceutical development
Immunoblotting techniques-ELISA, Western blotting, Southern blotting
Structure of immunoglobulins
Analytical cosmetics:BIS specification and analytical methods for shampoo, sk...
Basic principles of genetic engineering
Study of cloning vectors and recombinant dna technology
Use of microbes in industry. Production of enzymes-General consideration-Amyl...
Chemistry and formulation of para phenylene diamine based hair dye
Blood products:Collection, Processing and Storage of whole human blood, dried...
Soap and syndet bars evolution and skin benefits
An overview on coronavirus (COVID-19)
Compositon and Formulation of Transdermal drug delivery system
Excretion of drugs
Quality-by-design(QbD) in pharmaceutical development

Recently uploaded (20)

PDF
Hindi spoken digit analysis for native and non-native speakers
PPT
Geologic Time for studying geology for geologist
PDF
ENT215_Completing-a-large-scale-migration-and-modernization-with-AWS.pdf
PDF
Flame analysis and combustion estimation using large language and vision assi...
PDF
NewMind AI Weekly Chronicles – August ’25 Week III
PDF
Taming the Chaos: How to Turn Unstructured Data into Decisions
PPTX
Final SEM Unit 1 for mit wpu at pune .pptx
PPTX
2018-HIPAA-Renewal-Training for executives
PDF
A review of recent deep learning applications in wood surface defect identifi...
PDF
Getting started with AI Agents and Multi-Agent Systems
PPTX
Benefits of Physical activity for teenagers.pptx
PDF
Architecture types and enterprise applications.pdf
DOCX
search engine optimization ppt fir known well about this
PDF
Two-dimensional Klein-Gordon and Sine-Gordon numerical solutions based on dee...
PDF
Zenith AI: Advanced Artificial Intelligence
PDF
Convolutional neural network based encoder-decoder for efficient real-time ob...
PDF
A Late Bloomer's Guide to GenAI: Ethics, Bias, and Effective Prompting - Boha...
PDF
UiPath Agentic Automation session 1: RPA to Agents
PPTX
Custom Battery Pack Design Considerations for Performance and Safety
PPTX
Modernising the Digital Integration Hub
Hindi spoken digit analysis for native and non-native speakers
Geologic Time for studying geology for geologist
ENT215_Completing-a-large-scale-migration-and-modernization-with-AWS.pdf
Flame analysis and combustion estimation using large language and vision assi...
NewMind AI Weekly Chronicles – August ’25 Week III
Taming the Chaos: How to Turn Unstructured Data into Decisions
Final SEM Unit 1 for mit wpu at pune .pptx
2018-HIPAA-Renewal-Training for executives
A review of recent deep learning applications in wood surface defect identifi...
Getting started with AI Agents and Multi-Agent Systems
Benefits of Physical activity for teenagers.pptx
Architecture types and enterprise applications.pdf
search engine optimization ppt fir known well about this
Two-dimensional Klein-Gordon and Sine-Gordon numerical solutions based on dee...
Zenith AI: Advanced Artificial Intelligence
Convolutional neural network based encoder-decoder for efficient real-time ob...
A Late Bloomer's Guide to GenAI: Ethics, Bias, and Effective Prompting - Boha...
UiPath Agentic Automation session 1: RPA to Agents
Custom Battery Pack Design Considerations for Performance and Safety
Modernising the Digital Integration Hub

Present and future applications of biomaterials in controlled drug delivery system

  • 1. APPLICATION & SCOPE OF BIOMATERIAL IN CONTROLLED DRUG DELIVERY SYSTEM PRESENTED BY: STEFFI THOMAS M.PHARM (PHARMACEUTICS), 1ST SEM DEPARTMENT OF PHARMACY, BARKATULLAH UNIVERSITY
  • 2. CONTENTS  WHAT ARE BIOMATERIALS  APPLICATION IN PHARMACY  SAFETY OF BIOMATERIALS  BIOMATERIAL USED AS AN ADJUVANT IN DRUG DELIVERY SYSTEM  BIOMATERIAL AS ACTIVE PHARMACEUTICAL AGENT  SOURCES OF BIOMATERIALS  REGULATORY GUIDELINES FOR BIOMATERIALS  FUTURE PROSPECTS OF BIOMATERIALS  APPLICATIONS IN DISEASES  APPLICATIONS AS DRUG DELIVERY SYSTEM
  • 3. WHAT ARE BIOMATERIALS?  Biomaterial is essentially a material that is used and adopted for a medical application. Biomaterials can have a benign function such as being used for a heart valve, or may be bioactive; used for more interactive purpose such as hydroxy-apatite coated hip implants. Biomaterials are also used everyday in dental application, surgery and drug delivery.  Eg. Intra ocular lens, substitute heart valves, artificial hip joints
  • 4. APPLICATION IN PHARMACY  Cardiovascular medical devices(stents, grafts and etc.)  Orthopaedic and Dental applications(implant, tissue engineered scaffolds and etc.)  Ophthalmology applications(contact lens, retinal prosthesis and etc.)  Bioelectrodes and Biosensors  Burns Dressings and Skin substitutes  Sutures  Drug Delivery Systems
  • 5. SAFETY OF BIOMATERIALS  Biomaterials are non-viable materials that can be implanted to replace or repair missing tissue. They may be of natural origin or synthesized in a lab.  When used in a medical application, biomaterials can be implanted to replace or repair missing tissue.  Biomaterials, such as bone substitutes and collagen membranes, are used regularly in regenerative dentistry as well as for bone and cartilage regeneration in Orthopedics
  • 6. All Geistlich Biomaterials are derived from natural bovine or porcine material and have been developed to promote new bone or soft tissue formation. Due to their similarity to human tissue these material are optimally suited to promote new bone formation and soft tissue healing in the human body. They are integrated into the tissue in the course of healing process,or are broken down gradually by the body’s metabolic process.
  • 7. BIOMATERIALS USED AS AN ADJUVANT IN DRUG DELIVERY SYSTEMS  ‘Drug delivery’ involves the design and development of intelligent cargo carrier systems that can deliver their cargo (pharmaceutical/ biological agent) to specific parts (organs/tissues/cells) in the human body on demand with control on the rate of delivery.  Cargo-small molecules,DNA,RNA,Protein/peptide  Vehicle/Carrier-Polymeric,Lipid,Inorganic
  • 9.  Controlled Drug Release in Colon -For treatment of colon diseases such as inflammatory bowel disease, amoebic dysentery, Crohn’s disease and ulcerative colitis. -To delay drug absorption after oral intake of the drug. -Protect drugs from harsh acidic environment  Targeted Drug delivery -In Cancer a need for drug targeting is done so as to reduce side effects when drugs are selectively targeted to tumor tissue rather than administered systemically.
  • 10. -Targeting Drugs to Endothelial Cells as these cells play a crucial role in tumor development. Tumor survival is highly dependent on blood vessels which are comprised of endothelial cells.
  • 11. ACTIVE PHARMACEUTICAL AGENT Biomaterials also refer to biologically-derived materials used for their structural rather than biological properties, for example, collagen (a protein found in the skin, connective tissues and bone) as a cosmetic ingredient.  Also carbohydrates(biotechnologically modified) are being used as lubricants for biomedical applications and as bulking agents in pharmaceutical dosage form.  Micro-organisms have proven to be an excellent source of natural products including polyketides and peptide antibiotics as well as classes of other biological active compounds.
  • 12.  Plants produce a variety of different types of compounds including biologically active proteins. Some of these types of compounds are even shared with other organisms, and they include such chemical families as lactines, defensins, cyclotides and ribosome inactive proteins. Ribosome inactive proteins are a group of proteins exhibiting a wide spectrum of biological activities, including a ribonucleolytic activity for which the group is named. Thionins are small proteins that selectively form disulfide bridges with other proteins or form ion channels in membrane. This ability to make membrane more permeable suggests the
  • 13. SOURCES OF BIOMATERIALS  Biomaterials can be divided into 4 major classes of materials, namely: 1. Polymers 2. Metals 3. Ceramics(including carbon, glass-ceramics, and glasses) 4. Natural materials( those from both plants and animals, algae, microorganisms)
  • 14. REGULATORY GUIDELINES FOR BIOMATERIALS  Regulatory experts should be involved in basic research activities undertaken by consortia so as to raise awareness of the research decision implications in terms of regulatory path.  Regulation should not be looked in isolation but as a factor contributing to the acceptability of the products containing smart biomaterials by the health care system.  The requirements for evidence of safety and efficacy don’t only come from regulators but also from the end users and payers.
  • 15.  CENTER FOR DEVICES AND RADIOLOGICAL HEALTH(CDRH) ‘promotes’ and ‘protects’ the health of the public by ensuring the safety and effectiveness of medical devices and the safety of radiological products.  CDRH regulate devices, not materials and medical procedures
  • 16. FUTURE PROSPECTS OF BIOMATERIALS  SKIN TISSUE REGENERATION:In the field of regenerative skin tissue engineering has had several advancements to facilitate faster wound healing and thereby restoration of skin. Skin tissue regeneration is mainly based on the use of suitable scaffold matrices. There are several scaffold types, such as porous, fibrous, microsphere, hydrogel, composite and acellular etc.
  • 17.  GOLD NANOPARTICLES: These are spherical particles,nanorods,nanoshells and nanocages. Gold nanoparticles due to their enhanced and tunable optical properties have been used for drug delivery, photothermal therapy, cell tracking and sensing applications. This can be thus used for tumor diagnostic and treatment applications.  CERAMIC NANOPARTICLES: Ceramic nanoparticles which include alumina, zirconia, hydroxyapatite tricalcium phosphate and silicon nitride can be used for dental implants, hip replacements and tissue engineering scaffolds.
  • 18. APPLICATIONS IN DISEASES  EYE DISEASES: for the treatment of scleratis (sclera), glaucoma (retina), choroidal melanoma (choroid), diabetic retinopathy (retina), blindness, low vision by crossing tissue barriers. eg.contact lenses(poly(methyl methacrylate), silicone hydrogels) ,glaucoma(silicone impregnated with barium), vitreous replacements(silicone oil)
  • 19.  CARDIOVASCULAR DISEASES: Heart valves, endovascular stents, vascular grafts, stent grafts are common medical devices. Different polymers and metals with or without coating can be applied such as titanium, polytetrafluoroethylene etc.  BIOSENSORS AND BIOELECTRODES: Bioelectrodes are sensors used to transmit information into or out of the body. Surface or transcutaneous electrodes used to monitor or measure electrical events that occur in the body are considered monitoring or recording electrodes. Applications for recording electrodes include electrocardiography,
  • 20. Biosensor is a sensor that uses biological molecules, tissues, organisms or principles to measure chemical or biochemical concentrations. Biomedical sensors can be used to detect parameters: blood pressure or temperature(physical parameters), blood glucose.  DENTAL MATERIALS: Restorative materials have been used as tooth crowns and root replacements. Four group of materials used in dentistry are metals, ceramics, polymers and composites. Dental materials are classified into two categories:-preventive materials, restoration materials.
  • 21. APPLICATIONS AS DRUG DELIVERY SYSTEMS  Drug delivery systems introduced as formulations or instruments which enable to control he release rate of a biological agent(a drug) in the target site. By increasing the size the dosage in single dose administration, side effects would appear so in order to reduce them coatings with varying thickness, are applied. Such formulations are termed as “sustained release” or “prolonged release” products.
  • 22.  Macroscale DDS(“zero order” constant delivery rate DDS). -implants(e.g. Subcutaneous or intramuscular) -inserts(e.g. vaginal,ophthalmic) -topical DDS(e.g. skin patches)  Nanoscale DDS(targeted DDS) -injected nanocarrier DDS(e.g. PEGylated drugs, polymer-drug conjugates, PEGylated liposomes, PEGylated polymeric micelles)  Macroscale and microscale DDS(site-specific, sustained delivery rate DDS) -Surface-coated DDS(e.g. oral tablets, catheters, drug- eluting stents)
  • 23. REFERENCES  Lemons JE, Ratner BD, Hoffman AS, Schoen FJ (2013) Biomaterials science an introduction to materials in medicine, 3rd edn. Elsevier Ltd, Amsterdam.  Anusavice KJ(2003) Phillips’ science of dental materials. Elsevier health sciences.  www.cse.iitk.ac.in /-manindra / Website /... /MFT-08-Dhirendra Katti.ppt.pdf  Stikeman A.;Nano Biomaterials. Technology Review November 2002